Allergy and Immunology · Taunton, MA
NPI
1245214626
Since 2005
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
101 Industrial Park Rd
Taunton, MA, 02780
Phone (508) 880-3121
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
1,708 services
Medicare patients, 2024
138
Average age 70
Drug cost, 2024
$2.3M
1,210 prescriptions
Company payments, 2025
$2,975
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan J Katz was code 95004 (test - miscellaneous), 749 times for 17 patients. In total Alan J Katz billed 1,708 services in 24 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 749 | 17 | $2.96 | $2,220 |
| 95024 Test - Miscellaneous | Office | 466 | 15 | $6.56 | $3,058 |
| 99213 Office E&M - Established | Office | 67 | 60 | $60.09 | $4,026 |
| 95117 Treatment - Miscellaneous | Office | 60 | 21 | $6.08 | $365 |
| 99212 Office E&M - Established | Office | 48 | 47 | $28.93 | $1,389 |
| 94060 Pulmonary Function Testing | Office | 43 | 35 | $28.94 | $1,244 |
| 99214 Office E&M - Established | Office | 19 | 15 | $100.60 | $1,911 |
| 99203 Office E&M - New | Office | 16 | 16 | $88.63 | $1,418 |
| 99204 Office E&M - New | Office | 11 | 11 | $134.36 | $1,478 |
By year: 2022 $53K for 3,709 services; 2023 $48K for 3,344 services; 2024 $28K for 1,708 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 15 | $8.40 | $143 |
Medicare prescription drug claims, 2024
In 2024, the drug Alan J Katz prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 151 prescriptions and refills. In total Alan J Katz wrote 1,210 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 151 | 201 | 59 | $5,675 |
| Fluticasone Propionate Generic | 135 | 235 | 61 | $2,354 |
| Montelukast Sodium Generic | 130 | 279 | 52 | $2,040 |
| Azelastine Hcl Generic | 84 | 195 | 42 | $3,743 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 56 | 70 | 14 | $42K |
| Arnuity Ellipta Fluticasone Furoate | 51 | 61 | 16 | $16K |
| Ventolin Hfa Albuterol Sulfate | 51 | 57 | 22 | $3,188 |
| Breo Ellipta Fluticasone/Vilanterol | 48 | 56 | 14 | $22K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 43 | 63 | 14 | $4,280 |
| Ipratropium Bromide Generic | 38 | 93 | 21 | $1,237 |
| Epinephrine Generic | 33 | 33 | 23 | $4,749 |
| Levocetirizine Dihydrochloride Generic | 32 | 52 | Under 11 | $419 |
| Spiriva Respimat Tiotropium Bromide | 27 | 35 | Under 11 | $18K |
| Takhzyro Lanadelumab-Flyo | 25 | 25 | Under 11 | $1.3M |
| Prednisone Generic | 25 | 29 | 19 | $91.12 |
Brand drugs: 596 claims; generic drugs: 614 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan J Katz $2,975 ($2,975 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,561.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 62 | $1,561 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $210 |
| BioCryst US Sales Co., LLC | 5 | $181 |
| Genzyme Corporation SNY | 6 | $151 |
| CSL Behring CSL.AX | 8 | $146 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $140 |
| GC Biopharma USA, Inc. 006280.KS | 4 | $106 |
| GlaxoSmithKline, LLC. GSK | 4 | $95.07 |
| Pfizer Inc. PFE | 3 | $72.81 |
| Pharming Healthcare, Inc. | 3 | $66.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.